Australia’s latest earnings wave is revealing a significant shift in what investors are willing to reward, with capital increasingly moving towards companies positioned for long-term structural growth rather than simply strong headline profits.

CSL is a striking example. Its FY2026 results showed underlying NPATA falling 4 per cent to US$3.098 billion, while constant-currency revenue declined 1 per cent to US$15.371 billion. Yet the healthcare giant’s shares surged sharply as investors focused on restructuring, balance-sheet strength and the possibility of a stronger earnings trajectory.

The broader healthcare sector is also demonstrating how technology is reshaping Australian markets. Pro Medicus reported FY2026 revenue of A$261.7 million and underlying EBIT of A$196 million, producing an operating margin close to 75 per cent. The company also entered FY2027 with more than A$1.3 billion of recurring contract coverage over five years, highlighting the growing value of specialised healthcare software.

Meanwhile, BHP’s results point to another structural transition. Copper generated a record US$18 billion of EBITDA in FY2026, accounting for more than half of group EBITDA for the first time. BHP expects its copper business to remain cash-flow positive at consensus prices, supporting investment in future production.

This matters beyond mining. Copper demand is increasingly connected to electricity networks, data centres, renewable infrastructure and industrial electrification, giving resource companies exposure to the investment requirements of the digital economy.

Together, these results suggest Australia’s market is undergoing more than a routine earnings cycle. Healthcare technology, critical minerals and corporate restructuring are emerging as major themes. Investors appear increasingly focused on where businesses are heading next—and whether their assets, technology and balance sheets are positioned for the next decade.